These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 15533635

  • 1. The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia.
    Manten GT, van der Hoek YY, Marko Sikkema J, Voorbij HA, Hameeteman TM, Visser GH, Franx A.
    Med Hypotheses; 2005; 64(1):162-9. PubMed ID: 15533635
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) levels in women with pre-eclampsia and in normotensive pregnant women.
    Baksu B, Baksu A, Davas I, Akyol A, Gülbaba G.
    J Obstet Gynaecol Res; 2005 Jun; 31(3):277-82. PubMed ID: 15916667
    [Abstract] [Full Text] [Related]

  • 3. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z.
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [Abstract] [Full Text] [Related]

  • 4. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia.
    Mahmound RA, Abdel-Raouf M.
    East Mediterr Health J; 2006 Jul; 12(1-2):178-87. PubMed ID: 17037236
    [Abstract] [Full Text] [Related]

  • 5. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    Gynecol Obstet Invest; 2007 Jul; 64(1):8-13. PubMed ID: 17199090
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein(a) and the link between atherosclerosis and thrombosis.
    Koschinsky ML.
    Can J Cardiol; 2004 Aug; 20 Suppl B():37B-43B. PubMed ID: 15309204
    [Abstract] [Full Text] [Related]

  • 7. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia?
    Rousseau A, Favier R, Van Dreden P.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):46-9. PubMed ID: 19564071
    [Abstract] [Full Text] [Related]

  • 8. Is proteinuric pre-eclampsia a different disease in primigravida and multigravida?
    Barden AE, Beilin LJ, Ritchie J, Walters BN, Graham D, Michael CA.
    Clin Sci (Lond); 1999 Oct; 97(4):475-83. PubMed ID: 10491348
    [Abstract] [Full Text] [Related]

  • 9. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S, Karumanchi SA.
    Nephron Clin Pract; 2007 Oct; 106(2):c72-81. PubMed ID: 17570933
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study.
    van Pampus MG, Koopman MM, Wolf H, Büller HR, Prins MH, van den Ende A.
    Thromb Haemost; 1999 Jul; 82(1):10-3. PubMed ID: 10456446
    [Abstract] [Full Text] [Related]

  • 11. Newborns of pre-eclamptic women: a biochemical difference present in utero.
    Ophir E, Dourleshter G, Hirsh Y, Fait V, German L, Bornstein J.
    Acta Obstet Gynecol Scand; 2006 Jul; 85(10):1172-8. PubMed ID: 17068675
    [Abstract] [Full Text] [Related]

  • 12. Periodontal disease as a risk factor for pre-eclampsia: a case control study.
    Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, Ozgoz M, Demir T, Dilsiz A, Yagiz H.
    Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):568-73. PubMed ID: 15598299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impaired vascular dilatation in women with a history of pre-eclampsia.
    Lampinen KH, Rönnback M, Kaaja RJ, Groop PH.
    J Hypertens; 2006 Apr; 24(4):751-6. PubMed ID: 16531805
    [Abstract] [Full Text] [Related]

  • 15. Plasma from women with severe pre-eclampsia increases microvascular permeability in an animal model in vivo.
    Neal CR, Hunter AJ, Harper SJ, Soothill PW, Bates DO.
    Clin Sci (Lond); 2004 Oct; 107(4):399-405. PubMed ID: 15186215
    [Abstract] [Full Text] [Related]

  • 16. Preeclampsia and future cardiovascular risk.
    Newstead J, von Dadelszen P, Magee LA.
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):283-94. PubMed ID: 17338672
    [Abstract] [Full Text] [Related]

  • 17. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, Gonçalves L, Gomez R, Edwin S, Mazor M.
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [Abstract] [Full Text] [Related]

  • 18. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA, Ylikorkala O, Andersson S, Alfthan H, Stenman UH, Vuorela P.
    Acta Obstet Gynecol Scand; 2009 Jan; 88(5):593-8. PubMed ID: 19308751
    [Abstract] [Full Text] [Related]

  • 19. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia.
    Ray JG, Diamond P, Singh G, Bell CM.
    BJOG; 2006 Apr; 113(4):379-86. PubMed ID: 16553649
    [Abstract] [Full Text] [Related]

  • 20. Fetal lipoprotein changes in pre-eclampsia.
    Catarino C, Rebelo I, Belo L, Rocha-Pereira P, Rocha S, Castro EB, Patrício B, Quintanilha A, Santos-Silva A.
    Acta Obstet Gynecol Scand; 2008 Apr; 87(6):628-34. PubMed ID: 18568462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.